Figure 4From: Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassaysSimilarity analyses of benzylpiperazine (BZP) and mephentermine and prediction of immunoassay cross-reactivity. (A) 2D similarity of BZP to 287 amphetamine-like compounds. (B) 2D similarity of compounds that are cross-reactive, non-cross-reactive, or untested for the Neogen Benzylpiperazine Forensic ELISA. (C) 2D similarity of mephentermine to 287 amphetamine-like compounds. (D) 2D similarity of compounds that are cross-reactive, non-cross-reactive, or untested for the Neogen Mephentermine Forensic ELISA.Back to article page